Research News and Research

RSS

KVCI completes acquisition of former AAIPharma bioanalytical division

Kansas Venture Capital, Inc. (KVCI) has acquired the former AAIPharma bioanalytical division from ZeeCRO Inc. With its 30-year track record of developing entrepreneurial companies, KVCI will grow the bioanalytical business through organic and acquisition strategies to provide best-in-class analytical services for both the pharmaceutical and life sciences sectors.

18 Dec 2009

Autism Speaks calls on federal government to address the growing national autism public health crisis

In the wake of today's new report from the U.S. Centers for Disease Control (CDC) stating that autism now affects 1 in every 110 American children, Autism Speaks, the nation's largest autism science and advocacy organization, called on the federal government to immediately step up its efforts - and dramatically increase funding - to address the growing national autism public health crisis.

18 Dec 2009

Orphanage care in developing countries is a 'viable option,' study finds

A study, published on Thursday in PLoS One, finds that the "care at orphanages [in developing countries] is often at least as good as that given by families who take in orphaned or abandoned children," challenging "the widespread belief that orphans in poor countries fare best in family-style homes in the community and should be put into orphanages only as a last resort," the New York Times reports (Grady, 12/17).

18 Dec 2009

Recent releases in Global Health

A Scientific American article examines recent efforts to tackle neglected tropical diseases (NTDs). The author writes "NTDs have plagued humankind for thousands of years. … What is new, however, is that donors, drugmakers, health ministries in low- and middle-income countries, the World Health Organization (WHO), and public-private partnerships are linking their efforts to combat the NTDs in a more coordinated and systematic way."

18 Dec 2009

John Theurer Cancer Center presents over 20 research updates and trial results at the 2009 ASH meeting

Doctors and researchers from the John Theurer Cancer Center at Hackensack University Medical Center recently presented research updates and clinical trial results of more than 20 innovative studies at the American Society of Hematology (ASH) annual meeting from December 5-8, 2009.

18 Dec 2009

National Journal examines USAID administrator nominee's experience, prospects at the Agency

The National Journal looks at the professional background of Rajiv Shah, President Barack Obama's nominee to be the USAID administrator. "As Rajiv Shah prepares to lead the U.S. Agency for International Development, former colleagues, lobbyists and current and past administration officials paint a picture of a man with dizzying brainpower and social intelligence who has won over skeptics time and again.

18 Dec 2009

Roundup of health policy research and analyses

Urban Institute/Robert Wood Johnson Foundation: What Would Health Care Reform Mean for Small Employers and Their Workers? - "Small employers and their workers face a broad assortment of barriers to obtaining health insurance coverage today," such as "high administrative costs, limited ability to spread health care risk, and a low-wage workforce."

18 Dec 2009

Danaher offers GBP 50 million pounds for Genetix Group acquisition

Danaher Corporation announced today its intention to make a recommended cash takeover offer, through an indirect wholly owned subsidiary, to acquire all of the issued and to be issued shares of Genetix Group plc for 85 pence per share implying an aggregate price of approximately GBP 50 million pounds (USD $82 million) net of cash acquired.

From Danaher 18 Dec 2009

ABC News should focus more on integrity, says National Center for Public Policy Research

ABC News should focus less on Charlie Gibson and Diane Sawyer and more on integrity, says the National Center for Public Policy Research, which just completed an advertising review of ABC's nightly World News.

18 Dec 2009

Jubilant Organosys announces new facility for Niacinamide and 3-Cyanopyridine

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, announced today that it is setting up Niacinamide and 3-Cyanopyridine plant of 10,000 TPA each, expected to be ready by end of 2010.

18 Dec 2009

European CHMP announces positive opinion for Amgen's Prolia marketing authorization

Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

18 Dec 2009

University of Texas at Austin establishes new program to promote research on sports, media and culture

The College of Communication at The University of Texas at Austin has established the Texas Program in Sports and Media to foster interdisciplinary dialogue and research on sports, media and culture.

18 Dec 2009

New research into happiness levels of US citizens

New research by the UK's University of Warwick and Hamilton College in the US into the happiness levels of a million individual US citizens have revealed their personal happiness levels closely correlate with earlier research that ranked the quality of life available in the US's 50 states plus the District of Columbia. This research provides a unique external validation of people's self reported levels of happiness and will be of great value to future economic and clinical research in this field.

18 Dec 2009

Rosetta Genomics announces third-quarter 2009 financial results

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three and nine months ended September 30, 2009 and provided a business update.

18 Dec 2009

Medela announces award recipients from November Virtual Human Milk Collection Campaign

Medela announced today the award recipients from its November Virtual Human Milk (breastmilk) Collection Campaign in honor of the March of Dimes' National Prematurity Awareness Month. More than 4,100 participated in the campaign, voting for their preferred Neonatal Intensive Care Unit.

18 Dec 2009

NCD to address disability-related issues at next quarterly meeting

The National Council on Disability (NCD) will conduct its next quarterly meeting at the JW Marriott Houston, 5150 Westheimer, Houston, TX, beginning at 8:30 a.m. on Tuesday, January 19, 2010, and ending at 11:00 a.m. on Thursday, January 21, 2010. This meeting is open to the public.

18 Dec 2009

NYSSA’s market forecast luncheon to include a focus on healthcare

The New York Society of Security Analysts will present their biannual market forecast luncheon “Market Forecast: Return to Prosperity or False Dawn?” on January 7, 2010 which will include a special focus on healthcare. A panel of experts will discuss and debate the various crosscurrents in economic and financial market conditions facing investors.

18 Dec 2009

ANIS2's second edition on ‘micro and nanotechnologies for cancer research’ is open for registrations

There is still time until January 8 2010 to register for the second edition of the Alp NanoBio International School (ANIS2), which will be held in Sterzing/Vipiteno (Bozen, Italy) from 11 to 15 of January 2010, organized by the Centre of Excellence LATEMAR - funded by MIUR, in collaboration with the Fondazione Bruno Kessler (FBK).

18 Dec 2009

New stem cell based technology may eliminate brain cancer

Using a novel stem cell based technology of Cellonis Biotechnologies, Beijing, a Chinese research/medical team may eliminate a glioma -- brain cancer -- of a 36 year old Norwegian patient in a hospital in Beijing.

18 Dec 2009

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.

18 Dec 2009

Research News and Research

KVCI completes acquisition of former AAIPharma bioanalytical division

Autism Speaks calls on federal government to address the growing national autism public health crisis

Orphanage care in developing countries is a 'viable option,' study finds

Recent releases in Global Health

John Theurer Cancer Center presents over 20 research updates and trial results at the 2009 ASH meeting

National Journal examines USAID administrator nominee's experience, prospects at the Agency

Roundup of health policy research and analyses

Danaher offers GBP 50 million pounds for Genetix Group acquisition

ABC News should focus more on integrity, says National Center for Public Policy Research

Jubilant Organosys announces new facility for Niacinamide and 3-Cyanopyridine

European CHMP announces positive opinion for Amgen's Prolia marketing authorization

University of Texas at Austin establishes new program to promote research on sports, media and culture

New research into happiness levels of US citizens

Rosetta Genomics announces third-quarter 2009 financial results

Medela announces award recipients from November Virtual Human Milk Collection Campaign

NCD to address disability-related issues at next quarterly meeting

NYSSA’s market forecast luncheon to include a focus on healthcare

ANIS2's second edition on ‘micro and nanotechnologies for cancer research’ is open for registrations

New stem cell based technology may eliminate brain cancer

Biovator and BASF sign collaboration agreement to develop In Vitro test systems

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News